These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 25854877)
1. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule. Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression. Mitran B; Altai M; Hofström C; Honarvar H; Sandström M; Orlova A; Tolmachev V; Gräslund T Amino Acids; 2015 Feb; 47(2):303-15. PubMed ID: 25425114 [TBL] [Abstract][Full Text] [Related]
3. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors. Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326 [TBL] [Abstract][Full Text] [Related]
4. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules. Qi S; Hoppmann S; Xu Y; Cheng Z Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730 [TBL] [Abstract][Full Text] [Related]
5. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody. Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007 [TBL] [Abstract][Full Text] [Related]
6. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
7. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842 [TBL] [Abstract][Full Text] [Related]
8. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein. Miao Z; Ren G; Liu H; Jiang L; Cheng Z Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512 [TBL] [Abstract][Full Text] [Related]
9. Preclinical Evaluation of a New Format of Liu Y; Yu S; Xu T; Bodenko V; Orlova A; Oroujeni M; Rinne SS; Tolmachev V; Vorobyeva A; Gräslund T Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890370 [TBL] [Abstract][Full Text] [Related]
10. Imaging of insulinlike growth factor type 1 receptor in prostate cancer xenografts using the affibody molecule 111In-DOTA-ZIGF1R:4551. Tolmachev V; Malmberg J; Hofström C; Abrahmsén L; Bergman T; Sjöberg A; Sandström M; Gräslund T; Orlova A J Nucl Med; 2012 Jan; 53(1):90-7. PubMed ID: 22173843 [TBL] [Abstract][Full Text] [Related]
11. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma. Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955 [TBL] [Abstract][Full Text] [Related]
12. [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours. Orlova A; Hofström C; Strand J; Varasteh Z; Sandstrom M; Andersson K; Tolmachev V; Gräslund T Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):439-49. PubMed ID: 23179942 [TBL] [Abstract][Full Text] [Related]
13. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor. Luo H; Hong H; Slater MR; Graves SA; Shi S; Yang Y; Nickles RJ; Fan F; Cai W J Nucl Med; 2015 May; 56(5):758-63. PubMed ID: 25840981 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Chen K; Sun X; Niu G; Ma Y; Yap LP; Hui X; Wu K; Fan D; Conti PS; Chen X Mol Imaging Biol; 2012 Feb; 14(1):96-105. PubMed ID: 21360213 [TBL] [Abstract][Full Text] [Related]
15. PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using (64)Cu-Labeled Monoclonal Antibody 61B. Zhou B; Wang H; Liu R; Wang M; Deng H; Giglio BC; Gill PS; Shan H; Li Z Mol Pharm; 2015 Oct; 12(10):3527-34. PubMed ID: 26288060 [TBL] [Abstract][Full Text] [Related]
16. PET of vascular endothelial growth factor receptor expression. Cai W; Chen K; Mohamedali KA; Cao Q; Gambhir SS; Rosenblum MG; Chen X J Nucl Med; 2006 Dec; 47(12):2048-56. PubMed ID: 17138749 [TBL] [Abstract][Full Text] [Related]
18. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent. Brand C; Longo VA; Groaning M; Weber WA; Reiner T Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631 [TBL] [Abstract][Full Text] [Related]
19. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699 [TBL] [Abstract][Full Text] [Related]